WeGene Personal Genome Service Test

$ 99


Ancestry Composition
  • • Ancestry Composition
  • • Maternal Haplogroup
  • • Paternal Haplogroup
  • • Neanderthal Ancestry
Genetic Health Risk
  • • Late-Onset Alzheimer's Disease *
  • • Genetic risk for a form of dementia
  • • 1 variant in the APOE gene; variant found and studied in many ethnicities

There is a lot to consider with personal genome service test. We encourage you to review relevant information about ancestry and Genetic Health Risk reports on the Test information page.

只需 1mL 唾液,您就可以轻松在家获取个人基因检测报告,包含祖源、运动、营养、美肤、健康、心理等 9 大类,官方解读约 200 项报告(具体报告数以实际检测为准),提供 PDF 版报告且承诺终身免费更新。

WeGene 基于已有的数据库深度定制 Illumina BeadChip 基因芯片 (与其相同检测技术的芯片已被 FDA 批准用于非处方基因检测),不仅为中国群体特别优化,可用于探索族群起源,研究遗传相关的性状与疾病,还兼顾全球其他族群,快速且精准跟进最新科研成果。配合经 FDA 认证的 DNA Genotek 进口唾液采集管,严格把控每一个细节的质量,确保您的数据可靠和安全。

WeGene 检测标准版 2.0 不仅可以为每个用户提供 120 万个高解读价值的位点(核心数据),更有超过 2000 万个有潜在解读价值的位点(扩展数据),数据质量透明可见。您还可通过数据授权获取 300+ 项第三方解读报告,更好地探索自我。

Service steps


Register your collection kit


Mail it back

Discover your reports

Why WeGene

We aim to let people with East Asians ancestry benefit from knowing and understanding their genomic data.

The saliva collection kit

We use FDA-cleared saliva collection device for reliable, non-invasive collection, stabilization and transportation of high quality DNA.

Custom genotyping chip

We use custom designed lllumina iSelect array solutions, powered by BeadArray and Infinium technologies, provide trusted performance for genotyping your DNA.

*The WeGene Personal Genome Service test includes genetic health risk reports. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Warnings & Limitations: The WeGene Personal Genome Service Genetic Health Risk Report for Late-Onset Alzheimer’s Disease is indicated for reporting of the ε4 variant in the APOE gene. The report describes if a person has variants associated with a higher risk of Late-Onset Alzheimer’s Disease. This report does not include variants in other genes linked to Late-Onset Alzheimer’s Disease and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact Alzheimer’s Disease risk. The Personal Genome Service test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit https://www.wegene.com/en/intro/